Skip Nav Destination
Issues
Editorial
Research Articles
BRCA1 Wild-Type Allele Modifies Risk of Ovarian Cancer in Carriers of BRCA1 Germ-Line Mutations1
Sophie M. Ginolhac; Sophie Gad; Marilys Corbex; Brigitte Bressac-de-Paillerets; Agnès Chompret; Yves-Jean Bignon; Jean-Philippe Peyrat; Joelle Fournier; Christine Lasset; Sophie Giraud; Danièle Muller; Jean-Pierre Fricker; Agnès Hardouin; Pascaline Berthet; Christine Maugard; Catherine Nogues; Rosette Lidereau; Michel Longy; Sylviane Olschwang; Christine Toulas; Rosine Guimbaud; Drakoulis Yannoukakos; Csilla Szabo; Francine Durocher; Anne-Marie Moisan; Jacques Simard; Sylvie Mazoyer; Henry T. Lynch; David Goldgar; Dominique Stoppa-Lyonnet; Gilbert M. Lenoir; Olga M. Sinilnikova
Soluble Epidermal Growth Factor Receptor (sEGFR/sErbB1) as a Potential Risk, Screening, and Diagnostic Serum Biomarker of Epithelial Ovarian Cancer1
Andre T. Baron; Elsa M. Cora; Jacqueline M. Lafky; Cecelia H. Boardman; Marites C. Buenafe; Alfred Rademaker; Dachao Liu; David A. Fishman; Karl C. Podratz; Nita J. Maihle
The Efficacy of 9-Cis-Retinoic Acid (Aliretinoin) as a Chemopreventive Agent for Cervical Dysplasia: Results of a Randomized Double-Blind Clinical Trial1
Ronald D. Alvarez; Michael G. Conner; Heidi Weiss; Patricia M. Klug; Santosh Niwas; Upender Manne; James Bacus; Valeriy Kagan; Katherine C. Sexton; Clinton J. Grubbs; Isam-Eldin Eltoum; William E. Grizzle
Short Communications
Null Results in Brief
No Association Between Genetic Polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and Nasopharyngeal Carcinoma in Taiwan
Yu-Juen Cheng; Yin-Chu Chien; Allan Hildesheim; Mow-Ming Hsu; I-How Chen; Jerry Chuang; Julia Chang; Yunglin D. Ma; Cheng-Tai Luo; Wan-Lun Hsu; Helen Huei-Hsin Hsu; Hsin Huang; Jing-Fen Chang; Chien-Jen Chen; Czau-Siung Yang
Abstracts
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.